Sana Biotechnology is trading 5.05% lower at $2.35 in after-hours trading on October 15, 2026, with no clear company-specific announcement identified as a catalyst. - The shares closed the regular session at $2.48 after gaining 6.22%. - Available reporting said there was no fresh company news. An earlier report of a biotech-sector rise did not establish a direct catalyst, and mixed major-index moves were insufficient to attribute the decline to broader-market sentiment.